VZV-Induced Cerebellar Ataxia: Treatment Approach
No specific antiviral treatment is needed for VZV cerebellitis in immunocompetent patients, as the condition is typically self-limiting and resolves within 1-3 weeks. 1
Key Clinical Distinction
The critical first step is distinguishing VZV cerebellitis from VZV encephalitis, as treatment differs substantially:
VZV Cerebellitis (Pure Cerebellar Syndrome)
- Primary pathogenic mechanism: Immune-mediated demyelination, NOT direct viral cytopathology 1
- Clinical presentation: Isolated cerebellar signs (ataxia, dysmetria, truncal instability) without altered consciousness
- Treatment: Supportive care only 1
- Expected course: Self-limiting, resolves in 1-3 weeks 1
VZV Encephalitis (Altered Mental Status Present)
If the patient has any altered consciousness, confusion, or cognitive changes alongside cerebellar signs, this represents encephalitis requiring treatment:
Intravenous acyclovir 10 mg/kg three times daily for up to 14 days 1
Corticosteroids: Short course (e.g., prednisolone 60-80 mg daily for 3-5 days) often added due to inflammatory nature 1
- Stronger indication if vasculitic component or stroke-like features present 1
Important Clinical Caveats
Rash is NOT required for diagnosis: VZV cerebellitis can occur without any dermatological manifestations, even in immunocompetent adults 2, 3, 4. The absence of rash should not dissuade you from considering VZV.
Diagnostic confirmation:
- CSF analysis showing VZV DNA by PCR 2, 3, 4
- Anti-VZV IgM/IgG antibodies in serum and CSF 3
- CSF typically shows lymphocytic pleocytosis 4
Immunocompromised patients: Require prolonged intravenous acyclovir regardless of presentation 1
Practical Algorithm
Assess mental status carefully
- Normal consciousness + isolated cerebellar signs = cerebellitis → supportive care
- ANY altered consciousness = encephalitis → IV acyclovir + consider steroids
Look for vasculopathy features (stroke-like deficits, focal neurological signs)
- If present → IV acyclovir + corticosteroids 1
Check immune status
- Immunocompromised → treat with IV acyclovir regardless of presentation 1
Monitor for complications
The evidence consistently shows that pure VZV cerebellitis in immunocompetent patients does not benefit from antiviral therapy because the pathophysiology is immune-mediated rather than direct viral damage 1, 6. However, maintaining a low threshold for treatment is prudent if there is any diagnostic uncertainty or clinical deterioration.